80 results
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
with Innovation, Science & Economic Development Canada. The Investment Canada Act generally prohibits the implementation of a reviewable transaction unless
424B5
8930w
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
g1clhf05z xqni63cw
2 Apr 24
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
8:00am
8-K
EX-99.1
20piszz
2 Apr 24
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
8:00am
8-K
EX-99.1
kntyvswbaxw 4sh2jkly
27 Sep 23
Regulation FD Disclosure
7:30am
8-K
EX-99.1
wrvo6zuc60vws
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
424B5
b5wvgtsb35k zj4d
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
urd59
7 Jul 23
Prospectus supplement for primary offering
5:20pm
424B5
398 vodv343cu3
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
xrttn
6 Dec 22
Entry into a Material Definitive Agreement
9:25am
8-K
EX-99.1
9qk040necd cbym5b7
29 Sep 22
VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901
8:00am